Clinical Trial Update: Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety of the antithrombotic heparin proteoglycan mimetic APAC in peripheral arterial occlusive disease and chronic limb-threatenin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb-threatening Ischemia
• Peripheral Arterial Occlusive Disease

Drugs mentioned

• APAC (antithrombotic heparin proteoglycan mimetic)

Snippet

Sponsor: Aplagon Oy | Conditions: Peripheral Arterial Occlusive Disease, Chronic Limb-Threatening Ischemia | Phase 2 | Status: RECRUITING